NCT07022535View on ClinicalTrials.gov

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Interventions
DIAGNOSTIC_TEST

KELIM

"(i) Patients with KELIM \>=1 will receive radiological assessment and undergo interval debulking surgery if the disease is operable.~(ii) Patients with KELIM \<1 will have alternative management, such as addition of bevacizumab or changing to dose-dense chemotherapy, and defer the interval debulking surgery"

DRUG

Carboplatin plus Paclitaxel

Chemotherapy as neaodjuvant chemotherapy

PROCEDURE

Interval debulking surgery

Interval debulking surgery

Trial Locations (1)

Unknown

RECRUITING

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER